首页> 美国卫生研究院文献>Pathogens and Disease >From GFP to β-lactamase: advancing intact cell imaging for toxins and effectors
【2h】

From GFP to β-lactamase: advancing intact cell imaging for toxins and effectors

机译:从GFP到β-内酰胺酶:促进完整细胞成像以检测毒素和效应子

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Canonical reporters such as green fluorescent protein (GFP) and luciferase have assisted researchers in probing cellular pathways and processes. Prior research in pathogenesis depended on sensitivity of biochemical and biophysical techniques to identify effectors and elucidate entry mechanisms. Recently, the β-lactamase (βlac) reporter system has advanced toxin and effector reporting by permitting measurement of βlac delivery into the cytosol or host βlac expression in intact cells. βlac measurement in cells was facilitated by the development of the fluorogenic substrate, CCF2-AM, to identify novel effectors, target cells, and domains involved in bacterial pathogenesis. The assay is also adaptable for high-throughput screening of small molecule inhibitors against toxins, providing information on mechanism and potential therapeutic agents. The versatility and limitations of the βlac reporter system as applied to toxins and effectors are discussed in this review.
机译:诸如绿色荧光蛋白(GFP)和荧光素酶的规范报道者已协助研究人员探索细胞途径和过程。发病机理的先前研究取决于生化和生物物理技术的敏感性,以鉴定效应子并阐明进入机制。最近,β-内酰胺酶(βlac)报告系统通过允许测量完整细胞中向细胞溶胶或宿主中βlac表达的βlac传递,已经报道了先进的毒素和效应子报告。荧光底物CCF2-AM的开发促进了细胞中βlac的测定,以鉴定新型效应子,靶细胞和细菌发病机理中涉及的结构域。该测定法还适用于高通量筛选针对毒素的小分子抑制剂,提供有关机理和潜在治疗剂的信息。本文综述了βlac报告基因系统应用于毒素和效应子的通用性和局限性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号